Patent details

Basic Information

Publication number:

EP3354280

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP181612888

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-4 RECEPTOR (IL-4R) ANTIBODIES

French Title of Invention:

FORMULATIONS STABILISÉES CONTENANT DES ANTICORPS ANTI-RÉCEPTEUR DE L'INTERLEUKINE-4 (IL-4R)

German Title of Invention:

STABILISIERTE FORMULIERUNGEN MIT ANTI-INTERLEUKIN-4-REZEPTOR (IL-4R)-ANTIKÖRPERN

SPC Number:

Dates

Filing date:

05/10/2011

Grant date:

29/07/2020

EP Publication Date:

01/08/2018

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/07/2020

EP B1 Publication Date:

29/07/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/10/2020

Expiration date:

05/10/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/07/2020

 

 

Name:

Regeneron Pharmaceuticals, Inc.

Address:

777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, United States (US)

Inventor

1

Name:

TANG, Xiaolin

Address:

United States (US)

2

Name:

DIX, Daniel B.

Address:

United States (US)

Priority

Priority Number:

390283 P

Priority Date:

06/10/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 39/395; A61M 5/315; C07K 16/28; A61K 47/18;

Publication

European Patent Bulletin

Issue number:

202031

Publication date:

29/07/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages